Antibiotic Expenditure by Public Healthcare Institutions in Shandong Province in China, 2012–2016

Frontiers in Pharmacology

Volumn 9, Issue , 2018, Pages

  Yin, Jia ^a   Wu, Caixia ^b   Wei, Xiaolin ^c   Sun, Qiang ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG MEDICAL COLLEGE   (China)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

antibiotics; China; expenditure; public healthcare institutions; stewardship; zero mark up

Indexed keywords

EID: 85067818896     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2018.01396     Document Type: Article

References (35)

1. Alsan M., Schoemaker L., Eggleston K., Kammili N., Kolli P., Bhattacharya J., (2015). Out-of-pocket health expenditures and antimicrobial resistance in low-income and middle-income countries: an economic analysis. Lancet Infect. Dis. 15, 1203–1210. 10.1016/S1473-3099(15)00149-826164481
2. Center for Disease Dynamics Economics and Policy (2015). The State of the World's Antibiotics. Washington, DC: CDDEP.
3. Chinese Ministry of Health (1989). [Administrative Measures of hospital by hierarchy]. (No. 25). Beijing. Available online at: http://yygl.bjmu.edu.cn/zcfg/152415.htm
4. Davey P., Marwick C. A., Scott C. L., Charani E., McNeil K., Brown E., et al. (2017). Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst. Rev. 2:Cd003543. 10.1002/14651858.CD003543.pub428178770
5. Goossens H., Ferech M., Vander Stichele R., Elseviers M., (2005). Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 365, 579–587. 10.1016/S0140-6736(05)70799-615708101
6. Han S., Liang H., Su W., Xue Y., Shi L., (2013). Can price controls reduce pharmaceutical expenses? A case study of antibacterial expenditures in 12 Chinese hospitals from 1996 to 2005. Int. J. Health Serv. 43, 91–103. 10.2190/HS.43.1.g23527456
7. Kourlaba G., Kourkouni E., Spyridis N., Gerber J. S., Kopsidas J., Mougkou K., et al. (2015). Antibiotic prescribing and expenditures in outpatient paediatrics in Greece, 2010-13. J. Antimicrob. Chemother. 70, 2405–2408. 10.1093/jac/dkv09125881618
8. Liang W., Xie J., Fu H., Wu E. Q., (2014). The role of health economics and outcomes research in health care reform in China. Pharmacoeconomics 32, 231–234. 10.1007/s40273-014-0141-224554475
9. Liew Y. X., Krishnan P., Yeo C. L., Tan T. Y., Lee S. Y., Lim W. P., et al. (2011). Surveillance of broad-spectrum antibiotic prescription in Singaporean hospitals: a 5-year longitudinal study. PLoS ONE 6:e28751. 10.1371/journal.pone.002875122174889
10. Mao W. H., Chen W., (2015). The Zero Mark-up Policy for essential medicines at primary level facilities, China case study. Geneva World Health Organization.
11. National Bureau of Statistics of China (2017). [China Statistical Yearbook]. Beijing: China Statistics Press.
12. National Health Family Planning Commission (2009). [Further Standardize the Drug Centralized Bdiding Procurement in Hospitals]. (No. 7). Beijing. Available online at: http://www.sda.gov.cn/WS01/CL0056/35597.html
13. National Health Family Planning Commission (2013). [Notification of the Implementation Plan for Special Rectification on Nationwide Clinical Antibiotic Use]. (No.37). Beijing. Available online at: http://www.nhfpc.gov.cn/zwgkzt/wsbysj/200804/18786.shtml
14. National Health Family Planning Commission (2014). [Notification of the Implementation Plan for Special Rectification on Nationwide Clinical Antibiotic Use]. (No.300). Beijing. Available online at: http://www.moh.gov.cn/yzygj/s3593/201404/49973560ddde4293a489b158081d777c.shtml
15. National Health Family Planning Commission (2015). [Suggestions on Controlling the Irrational Increase of Medical Expenses in Public Healthcare Institutions]. (No.89). Beijing. Available online at: http://www.nhfpc.gov.cn/tigs/s3577/201511/0038da2bf8fe43d69511fb675e205d37.shtml
16. National Health and Family Planning Commission (2016). [China Health Statistics Yearbook]. Beijing: Peking Union Medical College Press.
17. National Health and Family Planning Commission (2017a). [China Health Statistics Yearbook]. Beijing: Peking Union Medical College Press.
18. National Health Family Planning Commission (2017b). [Notification for Improving Mangement of Clinical Antibiotic Use and Containing Antimicrobial Resistance] (No.10). Beijing. Available online at: http://www.moh.gov.cn/yzygj/s7659/201703/d2f580480cef4ab1b976542b550f36cf.shtml
19. O'Neill J., (2016). Tackling Drug-Resistant Infections Globally: Final Report and Recommendations. Available online at: https://amr-review.org/sites/default/files/160518_Final%20paper_with%20cover.pdf
20. Schellack N., Benjamin D., Brink A., Duse A., Faure K., Goff D., et al. (2017). A situational analysis of current antimicrobial governance, regulation, and utilization in South Africa. Int. J. Infect. Dis. 64, 100–106. 10.1016/j.ijid.2017.09.00228893672
21. Shi L., Yang H. Y., Cheng G., Meng Q., (2014). Time trends and determinants of pharmaceutical expenditure in China (1990-2009). Pharmacoeconomics 32, 257–264. 10.1007/s40273-013-0072-323827980
22. Suda K. J., Hicks L. A., Roberts R. M., Hunkler R. J., Matusiak L. M., Schumock G. T., (2018). Antibiotic expenditures by medication, class, and healthcare setting in the United States, 2010-2015. Clin. Infect. Dis. 66, 185–190. 10.1093/cid/cix77329020276
23. Toska A., Geitona M., (2015). Antibiotic resistance and irrational prescribing in paediatric clinics in Greece. Br. J. Nurs. 24, 28–33. 10.12968/bjon.2015.24.1.2825541873
24. Van Boeckel T. P., Gandra S., Ashok A., Caudron Q., Grenfell B. T., Levin S. A., et al. (2014). Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect. Dis. 14, 742–750. 10.1016/S1473-3099(14)70780-725022435
25. Wang J., Wang P., Wang X., Zheng Y., Xiao Y., (2014). Use and prescription of antibiotics in primary health care settings in China. JAMA Intern. Med. 174, 1914–1920. 10.1001/jamainternmed.2014.521425285394
26. Wang Y. Y., Du P., Huang F., Li D. J., Gu J., Shen F. M., et al. (2016). Antimicrobial prescribing patterns in a large tertiary hospital in Shanghai, China. Int. J. Antimicrob. Agents 48, 666–673. 10.1016/j.ijantimicag.2016.09.00828128095
27. Wei X., Yin J., Walley J. D., Zhang Z., Hicks J. P., Zhou Y., et al. (2017). Impact of China's essential medicines scheme and zero-mark-up policy on antibiotic prescriptions in county hospitals: a mixed methods study. Trop. Med. Int. Health 22, 1166–1174. 10.1111/tmi.1292228665490
28. WHO Collaborating Centre for Drug Statistics Methodology (2013). Guidelines for ATC Classification and DDD Assignment 2013. Norway: WHO.
29. World Bank (2016). Population, total-World Bank Open Data. Available online at: https://data.worldbank.org/indicator/SP.POP.TOTL?end=2017&locations=GB&start=2016
30. World Health Organization (2017). WHO List of Critically Important Antimicrobials for Human Medicine (WHO CIA list). Available online at: http://www.who.int/foodsafety/publications/cia2017.pdf?ua=1
31. Wushouer H., Tian Y., Guan X. D., Han S., Shi L. W., (2017). Trends and patterns of antibiotic consumption in China's tertiary hospitals: based on a 5 year surveillance with sales records, 2011-2015. PLoS ONE 12:e0190314. 10.1371/journal.pone.019031429281716
32. Yin J., Li Q., Sun Q., (2017). Antibiotic consumption in Shandong Province, China: an analysis of provincial pharmaceutical centralized bidding procurement data at public healthcare institutions, 2012-16. J. Antimicrob. Chemother. 73, 814–820. 10.1093/jac/dkx469
33. Zhang H., Hu H., Wu C., Yu H., Dong H., (2015). Impact of China's Public Hospital reform on healthcare expenditures and utilization: a case study in ZJ Province. PLoS ONE 10:e0143130. 10.1371/journal.pone.014313026588244
34. Zhang Q. Q., Ying G. G., Pan C. G., Liu Y. S., Zhao J., (2015). Comprehensive evaluation of antibiotics emission and fate in the river basins of China: source analysis, multimedia modeling, and linkage to bacterial resistance. Environ. Sci. Technol. 49, 6772–6782. 10.1021/acs.est.5b0072925961663
35. Zhang X., Wu Q., Liu G., Li Y., Gao L., Guo B., et al. (2014). The effect of the National Essential Medicines Policy on health expenditures and service delivery in Chinese township health centres: evidence from a longitudinal study. BMJ Open 4:e006471. 10.1136/bmjopen-2014-00647125534214